• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Reply to Rappaport : Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.对拉帕波特的回复：新冠病毒病中中等剂量血栓预防的抗Xa因子活性
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1733-1734. doi: 10.1164/rccm.202007-2913LE.
2
Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.新冠病毒感染中中等剂量血栓预防的抗Xa因子活性
Am J Respir Crit Care Med. 2020 Dec 15;202(12):1731-1733. doi: 10.1164/rccm.202006-2511LE.
3
Intermediate dose thromboprophylaxis in SARS-CoV-2 related venous thrombo embolism.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）相关静脉血栓栓塞症的中等剂量血栓预防
Eur J Intern Med. 2021 Jun;88:141-143. doi: 10.1016/j.ejim.2021.03.025. Epub 2021 Mar 26.
4
Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate.静脉血栓栓塞症及其与 COVID-19 的关联：仍存在争议。
Medicina (Kaunas). 2020 Sep 27;56(10):506. doi: 10.3390/medicina56100506.
5
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].[阿根廷COVID-19住院患者血栓预防用药建议]
Medicina (B Aires). 2020;80 Suppl 3:65-66.
6
Management of perioperative thromboprophylaxis for surgery following COVID-19: an expert-panel survey.COVID-19后手术围手术期血栓预防管理：专家小组调查
Br J Anaesth. 2021 Oct;127(4):e143-e145. doi: 10.1016/j.bja.2021.06.041. Epub 2021 Jul 9.
7
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.COVID-19 相关静脉血栓栓塞症：已报告风险和现行指南的系统综述。
Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15.
8
Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new "prudent" randomised clinical trial".对信件《新冠病毒肺炎患者真的需要高剂量依诺肝素进行血栓预防吗？一项新的“审慎”随机临床试验》的反驳
Blood Transfus. 2020 May;18(3):239-240. doi: 10.2450/2020.0116-20.
9
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?新冠病毒感染中的肺栓塞或肺血栓形成？使用高剂量肝素进行血栓预防的建议是否合理？
Thromb Haemost. 2020 Aug;120(8):1230-1232. doi: 10.1055/s-0040-1712097. Epub 2020 Apr 29.
10
Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).2019冠状病毒病（SARS-CoV-2感染）患者的静脉血栓栓塞——德国血管病学会（DGA）立场文件
Vasa. 2020 Jun;49(4):259-263. doi: 10.1024/0301-1526/a000885. Epub 2020 Jun 5.

本文引用的文献

1
Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?2019冠状病毒病的血栓预防：抗Xa因子——缺失的因素？
Am J Respir Crit Care Med. 2020 Aug 1;202(3):455-457. doi: 10.1164/rccm.202005-1654LE.
2
Heparin-Related Major Bleeding in Covid-19-Positive Patient: Perspective from the Outbreak.新冠病毒检测呈阳性患者的肝素相关严重出血：疫情视角
Cardiovasc Intervent Radiol. 2020 Aug;43(8):1216-1217. doi: 10.1007/s00270-020-02532-3. Epub 2020 May 28.
3
Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?新冠病毒感染死亡病例尸检中的血栓栓塞发现：肺血栓形成还是肺栓塞？
Ann Intern Med. 2020 Sep 1;173(5):394-395. doi: 10.7326/M20-3255. Epub 2020 May 15.
4
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.异常的凝血参数与新型冠状病毒肺炎患者的预后不良有关。
J Thromb Haemost. 2020 Apr;18(4):844-847. doi: 10.1111/jth.14768. Epub 2020 Mar 13.
5
Measuring anti-factor xa activity to monitor low-molecular-weight heparin in obesity: a critical review.测量抗Xa因子活性以监测肥胖患者的低分子量肝素：一项批判性综述。
Can J Hosp Pharm. 2015 Jan-Feb;68(1):33-47. doi: 10.4212/cjhp.v68i1.1423.

Reply to Rappaport : Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19.

作者信息

Dutt Tina, Simcox David, Downey Colin, McLenaghan Daniella, King Charlotte, Gautam Manish, Lane Steven, Burhan Hassan

机构信息

Liverpool University Hospitals National Health Service Foundation Trust Liverpool, United Kingdom.

Liverpool Clinical Laboratories Liverpool, United Kingdom and.

出版信息

Am J Respir Crit Care Med. 2020 Dec 15;202(12):1733-1734. doi: 10.1164/rccm.202007-2913LE.

DOI:10.1164/rccm.202007-2913LE
PMID:32931711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7737584/
Abstract
摘要